Metastatic melanoma - a review of current and future drugs
about
Metabolism under hypoxia in Tm1 murine melanoma cells is affected by the presence of galectin-3, a metabolomics approachFolated synperonic-cholesteryl hemisuccinate polymeric micelles for the targeted delivery of docetaxel in melanoma.Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo.The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.Therapeutic Inhibitors against Mutated BRAF and MEK for the Treatment of Metastatic Melanoma
P2860
Metastatic melanoma - a review of current and future drugs
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Metastatic melanoma - a review of current and future drugs
@en
Metastatic melanoma - a review of current and future drugs.
@nl
type
label
Metastatic melanoma - a review of current and future drugs
@en
Metastatic melanoma - a review of current and future drugs.
@nl
prefLabel
Metastatic melanoma - a review of current and future drugs
@en
Metastatic melanoma - a review of current and future drugs.
@nl
P2860
P356
P1433
P1476
Metastatic melanoma - a review of current and future drugs
@en
P2860
P304
P356
10.7573/DIC.212242
P577
2012-11-19T00:00:00Z